Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Down – Here’s What Happened

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) gapped down before the market opened on Friday . The stock had previously closed at $6.6170, but opened at $6.28. Coloplast A/S shares last traded at $6.33, with a volume of 222,079 shares changing hands.

Analyst Ratings Changes

A number of brokerages have commented on CLPBY. The Goldman Sachs Group cut Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a research note on Wednesday. Finally, Sanford C. Bernstein raised Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Coloplast A/S has an average rating of “Hold”.

Coloplast A/S Price Performance

The firm has a fifty day moving average price of $6.61 and a two-hundred day moving average price of $7.83. The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50. The stock has a market capitalization of $14.17 billion, a P/E ratio of 44.91, a P/E/G ratio of 2.04 and a beta of 0.15.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.01. The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.11 billion. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%. On average, analysts expect that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.